• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Sep 29, 2017
Clinical News

China approves HCV drugs from Gilead and AbbVie

BioCentury | Sep 25, 2017
Company News

Gilead's Sovaldi gets Chinese approval

BioCentury | Oct 3, 2016
Clinical News

Exviera dasabuvir: Phase IIIb data

BioCentury | Dec 3, 2015
Company News

FDA reviewing once-daily Viekira Pak

BioCentury | Oct 21, 2015
Clinical News

Shorter ABT-493/ABT-530 regimen yields 100% SVR4

BioCentury | Aug 17, 2015
Clinical News

Exviera dasabuvir: Phase IIIb data

BioCentury | May 11, 2015
Clinical News

Exviera dasabuvir: Preliminary Phase IIIb data

BioCentury | Apr 13, 2015
Clinical News

Exviera dasabuvir: Phase IIIb data

BioCentury | Apr 13, 2015
Clinical News

Exviera dasabuvir: Phase IIIb data

BioCentury | Apr 8, 2015
Top Story

Enanta gains on Phase II HCV data

Items per page:
1 - 10 of 104
Help Center
Username
Request Training
Submit Data Correction
Ask a Question